This site is intended only for healthcare professionals residing in Singapore
The World Health Organization (WHO) has declared that "antimicrobial resistance (AMR) is one of the top 10 global health threats facing humanity.”1
WHO urges that we all take immediate steps towards judicious use of antimicrobials.1 We agree.
In line with WHO principles, Pfizer’s PRESERVE strategy supports innovation and encourages sustainable, responsible use of and access to antimicrobials. We live these stewardship practices every day, so we can accelerate real change against resistance.
Our approach is based on 8 core pillars, each with its own targets and objectives.
|POLICY||Reward innovation,working towards a sustainable business model|
|PREVENTION||Vaccinate and promote infection prevention practices|
|EDUCATION||Raise awareness and ensure the responsible use of anti-infectives and vaccines|
|SURVEILLANCE||Measure and share AMR data to inform and support stewardship actions|
|EQUITY||Strengthen health systems to deliver quality care and improve patient access to medicines and vaccines|
|RESEARCH||Generate and communicate new antimicrobial resistance and/or stewardship-related data|
|VALUE & ACCESS||Share information about the value of antimicrobials, vaccines, and stewardship|
|PATIENT ENGAGEMENT||Inform and mobilize an engaged patient community|
For advocates of antimicrobial stewardship, diagnostic tools are critical.2,3
Diagnostic testing is essential to ensure patients receive the appropriate therapy earlier.
Using diagnostic tools reduces pathogen transmission, as people are infected for shorter
lengths of time, and supports good antimicrobial stewardship.2,3
Antimicrobial susceptibility testing can determine if an infection is likely to respond to a
particular antimicrobial therapy, and can lead to a more targeted treatment.3,4
Ordering the right tests for the right patient at the right time requires effective communication
and multidisciplinary collaboration.5 We must share diagnostic knowledge and expertise to get
closer to our goal: curb the threat of drug-resistant infections.
How do initiatives differ for antimicrobial, antibacterial, and antifungal stewardship?
Ayukekbong JA et al. Antimicrob Resist Infect Control 2017;6:47.
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
Copyright © 2023 Pfizer Limited. All rights reserved.